subject: Aarkstore Enterprise - China Antibodies [print this page] Aarkstore announce a new report "China Antibodies " through its vast collection of market research report.
With a rapidly growing economy, cost advantages, a skilled workforce, and a governmental commitment to the sciences, China is becoming increasingly important in the global biotechnology industry. Successful forays into high technology manufacturing and the increasing prestige of its scientific institutes have provided China with a strong platform for high-tech development.
China Antibodies is an essential resource for companies, investors and entrepreneurs interested in accessing Chinas antibody industry. This report offers a comprehensive overview and analysis of Chinas antibody industry together with a directory of more than 30 antibody-related enterprises. Detailed case studies and profiles of companies are included with information such as company size, customer segments, and executive profiles. This report includes cost data and addresses large-scale manufacturing.
Database of China Antibodies included: China Antibodies database includes 30+ Chinese antibody companies that produce antibody products or provide antibody services. Antibody products include antibodies for laboratory use, diagnostic use, and therapeutic antibodies. Antibody services refer to the tailored antibody preparation services including monoclonal and polyclonal antibody preparation. All of the antibody companies in the database include the following information :
I. Contact information
II. Company general information
III. Details on products and services provided
I. Introduction and Overview
II.History of Antibodies in China
III.The Market Landscape of Distributors
IV.Products
Antibodies for laboratory use
Antibodies for diagnostics
Protein chips
Antibody therapeutics
V.Services
Tailored preparation services
Cost analysis
VI.Antibody Technology Landscape in China
VII.Players and Business Models in the Antibody Industry
Institutes
Companies
VIII. Government and Regulatory
IX.The Future
X.Opportunities for Multinationals
XI. Leading Antibody Researchers in China
XII. Case Studies
XIII. Profiles
XIV. Directory
XV. Figures
1.History of therapeutic antibodies
2.China's unit volume for HBV, HCV, and HIV diagnostic products
3.Number of antibody service providers (monoclonal vs. polyclonal)
4.Price comparisons for New Zealand rabbits
5.Price comparisons for BALB/c mice
6.Antibody-related papers published in China from 1994-2004
